TG Therapeutics, Inc. (TGTX)

TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,245	2,586	1,719	2,716	6,840	1,105
Market Cap Growth	6.70%	50.41%	-36.69%	-60.29%	518.94%	225.15%
Enterprise Value	3,145	2,477	1,638	2,478	6,274	1,003
PE Ratio	95.82	204.08	-8.67	-7.80	-24.48	-6.39
PS Ratio	11.22	11.07	617.38	406.03	45000.79	7270.61
PB Ratio	20.27	16.11	29.35	11.45	13.17	28.62
P/FCF Ratio	160.01	-82.33	-9.76	-9.17	-31.83	-8.31
P/OCF Ratio	160.01	-82.33	-9.76	-9.19	-31.89	-8.32
EV/Sales Ratio	10.87	10.60	588.12	370.38	41274.62	6596.28
EV/EBITDA Ratio	58.40	95.67	-8.72	-7.24	-22.99	-5.99
EV/EBIT Ratio	58.59	96.45	-8.71	-7.23	-22.98	-5.98
EV/FCF Ratio	155.04	-78.84	-9.30	-8.37	-29.20	-7.54
Debt / Equity Ratio	0.69	0.68	1.39	0.33	0.08	1.01
Debt / EBITDA Ratio	2.05	4.22	-0.43	-0.23	-0.15	-0.23
Debt / FCF Ratio	5.44	-3.48	-0.46	-0.26	-0.19	-0.29
Quick Ratio	2.77	5.02	3.06	4.85	6.93	1.68
Current Ratio	3.62	5.92	3.16	5.06	6.99	1.77
Asset Turnover	0.92	0.87	0.01	0.02	0	0.00
Interest Coverage	4.45	2.04	-18.46	-60.74	-43.14	-31.70
Return on Equity (ROE)	31.30%	12.90%	-173.00%	-101.10%	-126.60%	-1527.00%
Return on Assets (ROA)	13.10%	4.70%	-82.10%	-76.50%	-86.20%	-143.90%
Return on Capital (ROIC)	17.70%	7.42%	-137.68%	-109.53%	-48.89%	-217.29%
Earnings Yield	1.27%	0.49%	-11.54%	-12.82%	-4.08%	-15.64%
FCF Yield	0.62%	-1.21%	-10.25%	-10.90%	-3.14%	-12.03%
Buyback Yield / Dilution	-4.20%	-9.67%	-2.41%	-14.64%	-30.51%	-17.10%
Total Shareholder Return	-4.20%	-9.67%	-2.41%	-14.64%	-30.51%	-17.10%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).